5 employees
NovaGray is developing the first predictive tests establishing patients’ sensitivity towards radiotherapy.
2015
$86K
from 2 investors over 2 rounds
NOVAGRAY raised $86K on May 1, 2018
Investors: Executive Agency for Small and Medium-sized Enterprises (EASME)
NOVAGRAY raised undisclosed on May 1, 2017
Investors: MedTech Innovator